Hajime Takikawa
- Hepatology top 0.5%
- Liver Diseases and Immunity 55
- Liver Disease and Transplantation 27
- Pharmacology top 0.05%
- Drug-Induced Hepatotoxicity and Protection 41
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 98
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 67
-
- Pharmacological Effects and Toxicity Studies 29
- Neonatal Health and Biochemistry 27
-
- Pediatric Hepatobiliary Diseases and Treatments 35
- Co-authors
- Neil KaplowitzAtsushi TanakaYuichi SugiyamaMasami YamanakaHiroshi SuzukiNaoyo SanoTomoko HirohashiAndrew Stolz
- Cited by
- HepatologyPharmacologyOncology
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (3 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Hajime Takikawa
220 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Hepatology 1.9k
- Pharmacology 1.6k
- Oncology 2.4k
- Epidemiology 2.1k
- Pediatrics, Perinatology and Child Health 1.1k
Countries citing papers authored by Hajime Takikawa
This map shows the geographic impact of Hajime Takikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Takikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Takikawa more than expected).
Fields of papers citing papers by Hajime Takikawa
This network shows the impact of papers produced by Hajime Takikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Takikawa. The network helps show where Hajime Takikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hajime Takikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 33 | |
| 6 | 2018 | 23 | |
| 7 | 2016 | 14 | |
| 8 | 2014 | 1 | |
| 9 | Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology | 2013 | 22 |
| 10 | 2012 | 2 | |
| 11 | 2010 | 2 | |
| 12 | 2009 | 0 | |
| 13 | 2008 | 3 | |
| 14 | 2007 | 1 | |
| 15 | Modified diagnostic criteria of drug-induced liver injury proposed by the international consensus meeting. | 2005 | 5 |
| 16 | 2002 | 43 | |
| 17 | 2002 | 5 | |
| 18 | 2000 | 264 | |
| 19 | 1985 | 29 | |
| 20 | 1983 | 71 |
About Hajime Takikawa
Hajime Takikawa is a scholar working on Hepatology, Pharmacology and Oncology, having authored 226 papers that have together received 5.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (98 papers), Liver Disease Diagnosis and Treatment (67 papers), Liver Diseases and Immunity (55 papers), Drug-Induced Hepatotoxicity and Protection (41 papers), Pediatric Hepatobiliary Diseases and Treatments (35 papers), Pharmacological Effects and Toxicity Studies (29 papers), Neonatal Health and Biochemistry (27 papers) and Liver Disease and Transplantation (27 papers). The work is most often cited by research in Hepatology (1.9k citations), Pharmacology (1.6k citations) and Oncology (2.4k citations). Hajime Takikawa has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Neil Kaplowitz, Atsushi Tanaka, Yuichi Sugiyama, Masami Yamanaka, Hiroshi Suzuki, Naoyo Sano, Tomoko Hirohashi, Andrew Stolz, Tomoe Beppu and Guruprasad P. Aithal. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.